Evidence map›Paper›PMID 41947729›Full record

SynthesisAddiction (Abingdon, England)2026

Prevalence of opium use and use disorder in the Iranian population: A systematic review and meta-analysis.

Maryam Ardeshir, Hosein Rafiemanesh, Yasna Rostam-Abadi, Jaleh Gholami, Masoumeh Amin-Esmaeili, Shahab Baheshmat, Marziyeh Hamzehzadeh, Kimia Farahmand, Ardavan Mohammad Aghaei, Anousheh Safarcherati and 1 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maryam ArdeshirIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-7972-9413
Hosein RafiemaneshNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Yasna Rostam-AbadiIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
Jaleh GholamiEdith Collins Centre, Translational Research for Alcohol, Drugs and Toxicology, Royal Prince Alfred Hospital, Camperdown, Australia.
Masoumeh Amin-EsmaeiliIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
Shahab BaheshmatDepartment of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Marziyeh HamzehzadehDepartment of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Kimia FarahmandIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
Ardavan Mohammad AghaeiIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
Anousheh SafarcheratiIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
Afarin Rahimi-MovagharIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-5761-1668

Funding

Iranian National Institute for Medical Research Development (NIMAD) 940043
6 · The paper itself

Abstract

BACKGROUND AND

aimsDespite historical and cultural roots, there is limited comprehensive data on the prevalence of opium use and use disorder across the Iranian population. We systematically reviewed the prevalence and trends of opium use and use disorder in Iran.

methodSystematic review and meta-analysis adhering to PRISMA guidelines, including studies from 1990 to 2023 across the Iranian general population, university students, the young population and specific populations. Measurements included the prevalence of opium use and use disorder by sex, time indicators (lifetime, last 12 months, last month/current, current daily or almost daily), study year and population subgroups.

resultsA total of 115 studies were included. Pooled prevalence of last 12-month opium use among the general population was 8.4% [95% confidence interval (CI) = 5.1-12.6%, studies = 6, n = 9302, I

conclusionsDespite global shifts to harder opioids, opium use continues to have a very high prevalence among the Iranian general population. While the overall prevalence appears stable, younger generations have shown a declining use pattern.

Indexed as

Opioid-Related DisordersOpium DependenceHumansIranMaleOpiumPrevalenceOpiumaddictionepidemiologyopioidopiumpublic healthsubstance use

Identifiers

PMID41947729
PMCPMC13357860

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.